Cargando…

Targeting PP2A for cancer therapeutic modulation

Protein phosphatases play essential roles as negative regulators of kinases and signaling cascades involved in cytoskeletal organization. Protein phosphatase 2A (PP2A) is highly conserved and is the predominant serine/threonine phosphatase in the nervous system, constituting more than 70% of all neu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ronk, Halle, Rosenblum, Jared S., Kung, Timothy, Zhuang, Zhengping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Compuscript 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630519/ https://www.ncbi.nlm.nih.gov/pubmed/36342229 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0330

Ejemplares similares

Acute worsening of CADASIL in a patient with COVID-19 infection: illustrative case
por: Rosenblum, Jared S., et al.
Publicado: (2022)

Carrimycin, a first in-class anti-cancer agent, targets selenoprotein H to induce nucleolar oxidative stress and inhibit ribosome biogenesis
por: Yu, LaYow C., et al.
Publicado: (2023)

Endogenous Retroviral Elements in Human Development and Central Nervous System Embryonal Tumors
por: Doucet-O’Hare, Tara T., et al.
Publicado: (2021)

Epigenetic Regulation in Primary CNS Tumors: An Opportunity to Bridge Old and New WHO Classifications
por: Dang, Danielle D., et al.
Publicado: (2023)

New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of Pediatric Medulloblastoma
por: Fang, Francia Y., et al.
Publicado: (2022)

Inhibition of PP2A with LB-100 Enhances Efficacy of CAR-T Cell Therapy Against Glioblastoma
por: Cui, Jing, et al.
Publicado: (2020)

New Developments in the Pathogenesis and Therapeutic Targeting of the IDH1 Mutation in Glioma
por: Dimitrov, Lilia, et al.
Publicado: (2015)

Progress and challenges towards targeted delivery of cancer therapeutics
por: Rosenblum, Daniel, et al.
Publicado: (2018)

PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer
por: Remmerie, Michiel, et al.
Publicado: (2019)

Epigenetic modulators as therapeutic targets in prostate cancer
por: Graça, Inês, et al.
Publicado: (2016)

PP2A and cancer epigenetics: a therapeutic opportunity waiting to happen
por: Tinsley, Samantha L, et al.
Publicado: (2022)

AXL in cancer: a modulator of drug resistance and therapeutic target
por: Tang, Yaoxiang, et al.
Publicado: (2023)

PP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast Cancer
por: Zhao, Henan, et al.
Publicado: (2017)

Exercise-mediated macrophage polarization modulates the targeted therapeutic effect of NAFLD: a review
por: Zhenyu, Li, et al.
Publicado: (2023)

Therapeutic Strategies and Biomarkers to Modulate PARP Activity for Targeted Cancer Therapy
por: Singh, Naveen, et al.
Publicado: (2020)

Metformin as a Therapeutic Target in Endometrial Cancers
por: Lee, Teresa Y., et al.
Publicado: (2018)

The non-coding RNAs of the H19-IGF2 imprinted loci: A focus on biological roles and therapeutic potential in Lung Cancer
por: Matouk, Imad J, et al.
Publicado: (2015)

Neurohormonal Modulation as a Therapeutic Target in Pulmonary Hypertension
por: García-Lunar, Inés, et al.
Publicado: (2020)

ATPase family AAA domain-containing protein 2 (ATAD2): From an epigenetic modulator to cancer therapeutic target
por: Fu, Jiahui, et al.
Publicado: (2023)

Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment
por: de Souza, Izadora, et al.
Publicado: (2022)

Inflammation in prostate cancer progression and therapeutic targeting
por: Stark, Timothy, et al.
Publicado: (2015)

Proteasome, a Promising Therapeutic Target for Multiple Diseases Beyond Cancer
por: Cao, Yu, et al.
Publicado: (2020)

Therapeutic Strategies Targeting Tumor Suppressor Genes in Pancreatic Cancer
por: Kuo, Kung-Kai, et al.
Publicado: (2021)

Trop-2 as a Therapeutic Target in Breast Cancer
por: Sakach, Elizabeth, et al.
Publicado: (2022)

SUN2: A potential therapeutic target in cancer
por: Chen, Xin, et al.
Publicado: (2019)

Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach
por: Chatterjee, Suman, et al.
Publicado: (2017)

Modulation of the CCR6-CCL20 Axis: A Potential Therapeutic Target in Inflammation and Cancer
por: Ranasinghe, Ranmali, et al.
Publicado: (2018)

PPI Modulators of E6 as Potential Targeted Therapeutics for Cervical Cancer: Progress and Challenges in Targeting E6
por: Chitsike, Lennox, et al.
Publicado: (2021)

PP1, PP2A and PP2B Interplay in the Regulation of Sperm Motility: Lessons from Protein Phosphatase Inhibitors
por: Ferreira, Ana F., et al.
Publicado: (2022)

Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease
por: Ko, Chih-Jan, et al.
Publicado: (2021)

PP2A(Cdc55/B55), a possible therapeutic target in cyclin D1-dependent cancers
por: Noguchi, Eishi
Publicado: (2013)

Role of protein phosphatases PP1, PP2A, PP4 and Cdc14 in the DNA damage response
por: Ramos, Facundo, et al.
Publicado: (2019)

Therapeutic Modulation of Apoptosis: Targeting the BCL-2 Family at the Interface of the Mitochondrial Membrane
por: Nemec, Kathleen N., et al.
Publicado: (2008)

Signaling pathways in cancer metabolism: mechanisms and therapeutic targets
por: You, Mengshu, et al.
Publicado: (2023)

PP2A-B55 Holoenzyme Regulation and Cancer
por: Goguet-Rubio, Perrine, et al.
Publicado: (2020)

Bile acids and their receptors: modulators and therapeutic targets in liver inflammation
por: Bertolini, Anna, et al.
Publicado: (2022)

Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway
por: Oon, Shereen, et al.
Publicado: (2016)

Epigenetic Modulators as Therapeutic Agents in Cancer
por: Patnaik, Eshaan, et al.
Publicado: (2023)

Human cytomegalovirus tegument proteins (pp65, pp71, pp150, pp28)
por: Tomtishen III, John Paul
Publicado: (2012)

Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer
por: Telkoparan-Akillilar, Pelin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2jrmags6lbavl1kvtq516g4o0m